{"slideshow_credits": null, "snippet": "The drug company reported a 25 percent increase in its second-quarter net income, dodging the expected drop in shares caused by generic competition.", "abstract": "Pfizer reports a 25 percent increase in its second-quarter net income as a result of aggressive cost-cutting; posts adjusted net income of $4.67 billion, or 62 cents a share; revenue totaled $15.06 billion, down 9 percent but above expectations of $14.93 billion.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/08/01/business/cost-cutting-helps-pfizer-beat-expectations.html", "lead_paragraph": "The drug company reported a 25 percent increase in its second-quarter net income, dodging the expected drop in shares caused by generic competition.", "headline": {"seo": "Cost-Cutting Helps Pfizer Beat Expectations", "main": "Cost-Cutting Helps Pfizer Beat Analysts&#8217; Expectations", "print_headline": "Cost-Cutting Helps Pfizer Beat Analysts\u2019 Expectations"}, "_id": "52b8b66b38f0d86bcb2a6e3c", "word_count": "436", "multimedia": [], "pub_date": "2012-08-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Pfizer Inc", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Lipitor (Drug)", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}